WALKING THE COMPLIANCE LINE: A REGULATORY LAWYER S PERSPECTIVE
|
|
- Meagan Bridges
- 8 years ago
- Views:
Transcription
1 WALKING THE COMPLIANCE LINE: A REGULATORY LAWYER S PERSPECTIVE Presented By: Alan B. Minsk Partner and Chair, Food and Drug Practice Team Arnall Golden Gregory LLP alan.minsk@agg.com Presented To: ISMPP Baltimore, MD April 23,
2 Before We Start Compliance is required by the law Compliance is good business Non-compliance is unlawful and bad for business The law is the law and applies to everyone 2
3 Renewed Government Interest Increase in FDA compliance personnel to review and enforce rules Justice Department and State scrutiny of product promotion is increasing Corporate Integrity Agreements, fines Bad Ad Program for Rx Drugs Do not have a false sense of security that the government won t review educational activities 3
4 Scientific Exchange vs. Promotion My Thoughts Education vs. spin Context and perception solicited vs. unsolicited request marketing vs. medical affairs greatest hits vs. entire reprint Relevance is the level of FDA regulation and oversight 4
5 Non-Promotional Information Some Examples Disease awareness communications Continuing Medical Education (CME) type activities Specific responses to unsolicited requests for information 5
6 Bottom Line (and to dispel misperception) Activities must be consistent with FDA guidelines regarding education and promotion e.g., no one at a company (or someone acting on behalf of the company) can promote off-label uses, suggest an investigational product is safe and effective, provide false or misleading information, or minimize risk FDA is more concerned about the content of the company s presentation of information than the title of the person providing the content 6
7 Off-Label Dissemination Off-label can result in misbranding, but misbranding (e.g., false or misleading information) and promoting an unapproved use can be separate violations FDA has issued guidance on proactive dissemination of off-label information (not promotion) in certain cases Good Reprint Practices guidance document (2009) we ve prepared a Bulletin if you would like a courtesy copy FDA has recently issued guidance on responding to requests for off-label information we ve prepared a Bulletin if you would like a courtesy copy Remember there is no safe harbor for disseminating false or misleading information Be careful about oral or verbal statements that can change a product s intended use hush, hush voices carry 7
8 Misbranding In short and in simplistic terms, not telling a complete, truthful story Ambiguity, misdirection, false comparisons to other products, and creating a false impression are also ways to misbrand a product Some buzzwords that might raise FDA scrutiny (although not necessarily illegal) all none more than better never best most er -ending comparisons safe and effective for an investigational product Minimization of risk information is of significant concern to FDA 8
9 Untitled Letter or Warning Letter Source of violations competitor complaints (majority) FDA monitoring e.g., review of periodicals, attendance at trade shows, websites, Form FDA-2253 inspections (of manufacturing facilities) complaints FDA s Bad Ad Campaign other agencies 9
10 Untitled Letter or Warning Letter (cont d) Some trends promotion of unapproved uses i.e., off-label uses general use clearance but promoted for specific use failure or minimization of adequate risk information promotion of unsubstantiated or misleading comparative claims overstatement of effectiveness 10
11 White Paper Enforcement Example Untitled Letter (2011) FDA picked up a company-prepared paper at a promotional exhibit booth in a commercial exhibit hall paper promoted investigational new drug as safe and effective broadened indication of an approved product (i.e., off-label) unsubstantiated effectiveness and superiority claims omitted and minimized important risk information 11
12 White Paper Enforcement Example (cont d) The placement of the white paper on the counter top at the promotional exhibit booth in the commercial exhibit hall during open exhibit hours made it available to all conference attendees, including physicians and other healthcare providers involved in the decision process for treating patients The FDA representative was neither approached by a company representative when the white paper was obtained nor was a PI offered or attached to the piece FDA noted that the white paper bore a company material ID code, similar to those used as identifiers on promotional materials when they are submitted to FDA, which implied the paper was being used as a promotional piece 12
13 Another Enforcement Example Warning Letter (2010) white paper omitted important risk information, broadened the product s indication, and failed to provide adequate directions for use established name and brand name not used, but FDA concluded the piece was branded and promotional (e.g., company name and logo, only approved product for the indication, colors used that were similar to the other productpromotional pieces) 13
14 Other Possible Ramifications Corrective advertising Loss of credibility with FDA and the marketplace Diversion of $$$ from other projects to correct violative message 14
15 Some Key Takeaways From FDA Enforcement The agency has maintained (and the courts have upheld elsewhere) that false speech is not protected commercial speech Promotions that are highly visible increase risk e.g., national medical conference, TV Promotions that raise safety concerns are likely to trigger FDA action 15
16 Other Non-FDA Implications One Thing Leads to Another Bad publicity Whistleblower complaints Product liability State prosecution Fraud prosecution and abuse False Claims Act, Anti- Kickback (e.g., preceptorships, grants, publications, ghostwriting) Loss of good reputation in the medical and patient communities Other regulatory agencies e.g., SEC, FTC Competitor challenges Individual liability 16
17 Recommendations All materials disseminated should be reviewed internally accuracy and appropriateness of information balance of information and regulatory compliance Don t get hung up with titles, such as Medical Communications the government is more concerned with content and message educate internally about role difference and separate training for respective groups independence of Medical Affairs in both company structure and funding roles 17
18 Recommendations (cont'd) Make clear what s approved and what s investigational No homemade materials includes highlighting an article or spinning the information Promote only to audience that can lawfully prescribe/take product Be careful about symbols, logos, or graphics that can also get a company into trouble with intended use issues 18
19 Recommendations (cont'd) Did the company submit data during review process and what was FDA s response? If FDA rejected a claim during the regulatory review process, you would be ill-advised to promote that claim Always have substantiation for claims and tell the whole story Disclaimers or qualifying statements are helpful but won t eliminate risk if the whole promotion, when viewed in full and in context, is violative 19
20 Recommendations (cont'd) Items that are distributed should be recorded in case the company must take corrective action at a later date, which is one reason that there should be a central place that disseminates requested information Train employees and third parties you employ about company policies and monitor/audit them you don t want renegade individuals getting the company in trouble audit internally to make sure everyone is on the same page 20
21 21
Introduction to Compliance with FDA Labeling and Advertising Requirements
Introduction to Compliance with FDA Labeling and Advertising Requirements Second Annual Pharmaceutical Industry Regulatory and Compliance Summit Dick Kenny FDA History Basic function of government Oldest
More informationDUVAL CLIENT ALERT December 2009
1 P a g e DUVAL CLIENT ALERT December 2009 In this DUVAL CLIENT ALERT, we list practical ways medical device companies can lawfully communicate about their products prior to FDA clearance or approval.
More informationWhy do we have Speaker Compliance Guidelines and Training?
Disclaimer The views expressed in this presentation are the views of the facilitators and do not necessarily represent the views or policies of our employer. Why do we have Speaker Compliance Guidelines
More informationInterplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation
Interplay Between FDA Advertising and Promotion Enforcement Activities, Product Liability, and Consumer Fraud Litigation Leslie M. Tector Quarles & Brady LLP September 30, 2014 Objectives Which federal
More informationMedical Device Industry. industry developments and stay ahead. of the challenges. Health care law has been the. cornerstone of our law firm for nearly
ebglaw.com introduction The medical device industry has seen significant growth in recent years. This has led to an increase in government regulations and enforcement efforts. attorneys help our clients
More informationAmgen GLOBAL CORPORATE COMPLIANCE POLICY
1. Scope Applicable to all Amgen Inc. and subsidiary or affiliated company staff members, consultants, contract workers and temporary staff worldwide ( Covered Persons ). Consultants, contract workers,
More informationCopyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited.
Copyright. Jeremiah J. Kelly (2015). All rights reserved. Further dissemination without express written consent strictly prohibited. Sources of Regulation 502(n) added to the FD&C Act in the Kefauver-Harris
More information2012-2013 MEDICARE COMPLIANCE TRAINING EMPLOYEES & FDR S. 2012 Revised
2012-2013 MEDICARE COMPLIANCE TRAINING EMPLOYEES & FDR S 2012 Revised 1 Introduction CMS Requirements As of January 1, 2011, Federal Regulations require that Medicare Advantage Organizations (MAOs) and
More informationFraud, Waste & Abuse. Training Course for UHCG Employees
Fraud, Waste & Abuse Training Course for UHCG Employees Overview The Centers for Medicare & Medicaid Services (CMS) require Medicare Advantage Organizations and Part D Plan Sponsors to provide annual fraud,
More informationFraud and Abuse in the Sale and Marketing of Drugs
American Conference Institute s 11 th National Forum on: Fraud and Abuse in the Sale and Marketing of Drugs MANAGING, DEFENDING AND CURTAILING WHISTLEBLOWER AND RELATOR ALLEGATIONS UNDER ANEXPANDED FALSE
More information2010 Fraud, Waste, and Abuse Training Materials
2010 Fraud, Waste, and Abuse Training Materials UnitedHealthcare Medicare Plans Medicare Advantage AARP MedicareComplete Erickson Advantage Evercare Sierra Spectrum Sierra Village Health SM SecureHorizons
More informationU.S. CORPORATE ETHICS AND COMPLIANCE POLICY
U.S. CORPORATE ETHICS AND COMPLIANCE POLICY Table of Contents Page 1. Letter from the President & CEO 3 2. Introduction 4 3. How to Handle and Report Ethical and/or Compliance Issues 5 3.1 Violations of
More informationProducts Liability: Putting a Product on the U.S. Market. Natalia R. Medley Crowell & Moring LLP 14 November 2012
Products Liability: Putting a Product on the U.S. Market Natalia R. Medley Crowell & Moring LLP 14 November 2012 Overview Regulation of Products» Federal agencies» State laws Product Liability Lawsuits»
More informationPrescription Drug Information for Patients: History
Prescription Drug Information for Patients: History 1500s: Ethical Statutes of Royal College of Physicians Let no physician teach the people about medicines or even tell them the names of the medicines,
More informationPROMOTING MEDICAL DEVICES WITHIN FDA LAW AND POLICY. OUTLINE (March 2001)
PROMOTING MEDICAL DEVICES WITHIN FDA LAW AND POLICY OUTLINE (March 2001) Dvorah A. Richman, Esq. Partner King & Spalding 1730 Pennsylvania Ave., N.W. Washington, D.C. 20006 202-626-2948 drichman@kslaw.com
More informationFraud Waste and Abuse Training First Tier, Downstream and Related Entities. ONECare by Care1st Health Plan Arizona, Inc. (HMO) Revised: 10/2009
Fraud Waste and Abuse Training First Tier, Downstream and Related Entities ONECare by Care1st Health Plan Arizona, Inc. (HMO) Revised: 10/2009 Overview Purpose Care1st/ ONECare Compliance Program Definitions
More informationPolicies and Procedures SECTION:
PAGE 1 OF 5 I. PURPOSE The purpose of this Policy is to fulfill the requirements of Section 6032 of the Deficit Reduction Act of 2005 by providing to Creighton University employees and employees of contractors
More informationELEMENT FINANCIAL CORPORATION CODE OF BUSINESS CONDUCT AND ETHICS
APPENDIX I ELEMENT FINANCIAL CORPORATION CODE OF BUSINESS CONDUCT AND ETHICS As of December 14, 2011 1. Introduction This Code of Business Conduct and Ethics ( Code ) has been adopted by our Board of Directors
More informationRegulatory Affairs Professionals Society: Regulatory Affairs Certification (RAC) Study Group FDA Regulation of Advertising and Promotion
Regulatory Affairs Professionals Society: Regulatory Affairs Certification (RAC) Study Group FDA Regulation of Advertising and Promotion Alex Toy July 14, 2013 1 Agenda FDA Regulatory Framework Office
More informationBehavioral Healthcare, Inc. 155 Inverness Drive West Suite 201 Englewood, CO 80112
1 of 6 I. Policy: It is the policy of Behavioral Healthcare, Inc. (BHI) that all employees (including management, consultants, contractors, and other agents) shall comply with all applicable Federal and
More informationNewport Subacute Healthcare Center
Title: False Claims Act Policy Manual: Administrative Policy Manual Category: Business function Approval Signatures: Newport Subacute Healthcare Center Document #: Original Issue: 02/01/2006 Revision Date:
More informationHealth Care & Social Media. Best Practice Marketing Strategies
Health Care & Social Media Best Practice Marketing Strategies Speakers Jennifer R. Breuer Partner Drinker Biddle & Reath, LLP Jennifer.Breuer@dbr.com (312) 569-1256 Darren S. Cahr Partner Drinker Biddle
More informationFraud Prevention Training Requirements For Medicare Advantage Plans
MEDICARE ADVANTAGE (Part C) PRESCRIPTION DRUG (Part D) FRAUD, WASTE, and ABUSE EDUCATION AND TRAINING 1 INTRODUCTION CMS has mandated that Medicare Advantage Organizations (MAOs) and Prescription Drug
More informationCHAMPAIGN COUNTY NURSING HOME SUMMARY OF ANTI-FRAUD AND ABUSE POLICIES
1. PURPOSE CHAMPAIGN COUNTY NURSING HOME SUMMARY OF ANTI-FRAUD AND ABUSE POLICIES Champaign County Nursing Home ( CCNH ) has established anti-fraud and abuse policies to prevent fraud, waste, and abuse
More informationYoungevity Essential Life Sciences & Youngevity International, Inc.
Youngevity Essential Life Sciences & Youngevity International, Inc. Guidelines for Distributor created and maintained websites The following excerpts from Youngevity s Policies and Procedures are compiled
More informationCase Study Sanctura. (trospium chloride)
Case Study Sanctura (trospium chloride) Bad Ad Case Study Sanctura (trospium chloride) Facilitator Guide Approximate Time: 30 minutes Exercise prerequisite: Students should view the Bad Ad e-learning CME/CE
More informationStandards of. Conduct. Important Phone Number for Reporting Violations
Standards of Conduct It is the policy of Security Health Plan that all its business be conducted honestly, ethically, and with integrity. Security Health Plan s relationships with members, hospitals, clinics,
More informationGreen Marketing GREEN MARKETING. Your Environmental Claims Must Be Accurate and Not Misleading
GREEN MARKETING Today, it seems that every company has a green story. And no wonder. Not only does the development and offering of green products and services positively impact consumer and investor perceptions
More informationIntroduction. Both the government and the public will have visibility in an area that was previously opaque
Sunshine Data: Will it Help Qui Tam Whistleblowers and their Attorneys? P H A R M A C E U T I C A L C O M P L I A N C E F O R U M S I X T H A N N U A L S U M M I T O N D I S C L O S U R E, T R A N S P
More informationFraud Waste and Abuse Training First Tier, Downstream and Related Entities
Fraud Waste and Abuse Training First Tier, Downstream and Related Entities Revised: 04/2010 OVERVIEW Centene Corporation Purpose Bridgeway Compliance Program Definitions of Fraud Waste & Abuse Laws and
More informationSecond Circuit Vacates Off-Label Promotion Conviction on First Amendment Grounds in U.S. v. Caronia
December 20, 2012 Second Circuit Vacates Off-Label Promotion Conviction on First Amendment Grounds in U.S. v. Caronia For more information, contact: Edward M. Basile +1 202 626 2903 ebasile@kslaw.com Pam
More informationBAD CONSUMER REVIEWS ONLINE: STRATEGIES FOR REMOVAL
BAD CONSUMER REVIEWS ONLINE: STRATEGIES FOR REMOVAL By: Karl Kronenberger Marketing professionals often struggle to make the best decision regarding negative content about their business s brand on Yelp
More informationAAD ADVERTISING STANDARDS
Approved: Board of Directors 11/14/09 AAD ADVERTISING STANDARDS The American Academy of Dermatology and AAD Association (collectively, the Academy ) seeks to advance the science and art of dermatology
More informationPrinciples Governing Academy Relationships with External Sources of Support
Principles Governing Academy Relationships with External Sources of Support Adopted by American Academy of Neurology American Academy of Neurology Institute American Brain Foundation June 2013 I. Preamble
More informationE-ALERT Food & Drug 2012 END-OF-YEAR SUMMARY OF FDA PROMOTIONAL ENFORCEMENT ACTIVITY OFFICE OF PRESCRIPTION DRUG PROMOTION (OPDP) ENFORCEMENT ACTIVITY
E-ALERT Food & Drug March 18, 2013 2012 END-OF-YEAR SUMMARY OF FDA PROMOTIONAL ENFORCEMENT ACTIVITY This client alert reviews the warning and untitled letters issued in 2012 by the Office of Prescription
More informationRE: NDA: 021876 DICLEGIS (doxylamine succinate and pyridoxine hydrochloride) delayed-release tablets, for oral use MA # 350 WARNING LETTER
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Silver Spring, MD 20993 TRANSMITTED BY FACSIMILE Eric Gervais, Executive Vice President 919 Conestoga Road Building
More informationBad Ads Trend Alert: False Claims in Online Weight Loss Advertisements. June 2014. TrustInAds.org. Keeping people safe from bad online ads
Bad Ads Trend Alert: False Claims in Online Weight Loss Advertisements June 2014 TrustInAds.org Keeping people safe from bad online ads EXECUTIVE SUMMARY Today, the sale of numerous weight loss products
More informationTM Nightingale. Home Healthcare. Fraud & Abuse: Prevention, Detection, & Reporting
Fraud & Abuse: Prevention, Detection, & Reporting What Is Fraud? Fraud is defined as making false statements or representations of facts to obtain benefit or payment for which none would otherwise exist.
More informationUr-Energy Inc. Code of Business Conduct and Ethics
Ur-Energy Inc. Code of Business Conduct and Ethics As Amended Effective February 5, 2014 2957409.2 TABLE OF CONTENTS INTRODUCTION... 3 CONFLICTS OF INTEREST... 3 GIFTS, INVITATIONS AND ENTERTAINMENT GUIDELINES...
More informationUse of Social Media by Pharmaceutical Medical Information Teams
www.arisglobal.com A White Paper Presented By ArisGlobal Use of Social Media by Pharmaceutical Medical Information Teams Ome Ogbru, PharmD, Medical Information SME What is Social Media? The Merriam-Webster
More informationCODE OF CONDUCT. Providers, Suppliers and Contractors
CODE OF CONDUCT Providers, Suppliers and Contractors Table of Contents Code of Conduct... Honesty and integrity... Quality and Service... Responsibilities of Providers, Suppliers and Contractors... Compliance
More informationThis policy applies to UNTHSC employees, volunteers, contractors and agents.
Policies of the University of North Texas Health Science Center 3.102 Detecting and Responding to Fraud, Waste and Abuse Chapter 3 Compliance Policy Statement UNTHSC developed and implemented a Compliance
More informationCOMPLIANCE AND OVERSIGHT MONITORING
COMPLIANCE AND OVERSIGHT MONITORING The contract between HCA and Molina Healthcare defines a number of performance requirements that must be satisfied by Molina Healthcare subcontracted Providers to provide
More informationCommercial. Sales Guidelines. Christine Varner, Health Net We help make whole health possible. For California Agents/Brokers
Commercial Sales Guidelines Christine Varner, Health Net We help make whole health possible. For California Agents/Brokers Health Net of California, Inc. and Health Net Life Insurance Company (collectively
More informationOPINION 2015-2 Issued August 7, 2015. Direct In-person Solicitation of Prospective Clients at Seminars
BOARD OF PROFESSIONAL CONDUCT 65 SOUTH FRONT STREET, 5 TH FLOOR, COLUMBUS, OH 43215-3431 Telephone: 614.387.9370 Fax: 614.387.9379 www.supremecourt.ohio.gov PAUL M. DE MARCO CHAIR WILLIAM J. NOVAK VICE-
More informationCompliance and Program Integrity Melanie Bicigo, CHC, CEBS mlbicigo@uphp.com 906-225-7749
Compliance and Program Integrity Melanie Bicigo, CHC, CEBS mlbicigo@uphp.com 906-225-7749 Define compliance and compliance program requirements Communicate Upper Peninsula Health Plan (UPHP) compliance
More informationWestlake Convalescent Hospital
Title: False Claims Act Policy Manual: Administrative Policy Manual Category: Business function Approval Signatures: Westlake Convalescent Hospital Document #: Original Issue: 02/01/2006 Revision Date:
More informationUSC Office of Compliance
PURPOSE This policy complies with requirements under the Deficit Reduction Act of 2005 and other federal and state fraud and abuse laws. It provides guidance on activities that could result in incidents
More informationFair Market Value and Payments to Healthcare Professionals How Should We Determine What We Pay? Huron Consulting Services LLC. All rights reserved.
Fair Market Value and Payments to Healthcare Professionals How Should We Determine What We Pay? Huron Consulting Services LLC. All rights reserved. Contact Information Debjit Ghosh Life Sciences Practices
More informationGuidance for Industry
Guidance for Industry Promoting Medical Products in a Changing Healthcare Environment; I. Medical Product Promotion by Healthcare Organizations or Pharmacy Benefits Management Companies (PBMs) DRAFT GUIDANCE
More informationAdvisory Opinion #09-01114-A Personal Injury Print Advertisement Use of Superlatives and Monetary Verdicts
STATEWIDE GRIEVANCE COMMITTEE Advisory Opinion #09-01114-A Personal Injury Print Advertisement Use of Superlatives and Monetary Verdicts Pursuant to Practice Book 2-28B, the undersigned, duly-appointed
More informationOur school clients and some
Internet Marketing 2010 The Baxandall Co., Inc. Published by Workforce Communications www.careereducationreview.net Taming the Wild, Wild West of Lead Generation Legal Considerations and Remedies By Michelle
More informationMarketing Products Without Getting Hammered by FDA
Global CompliancePanel Knowledge, a Way Forward 2-day In-person Seminar: Marketing Products Without Getting Hammered by FDA Chicago, IL July 21st & 22nd, 2016 9:00 AM to 6:00 PM Price Price: $1,295.00
More informationANNUAL AGENT BULLETIN
ANNUAL AGENT BULLETIN October 2015 Transamerica Life Insurance Company Transamerica Financial Life Insurance Company Transamerica Advisors Life Insurance Company Transamerica Premier Life Insurance Company
More informationThe Legal Risks in Marketing Your Practice: Ask the Attorney
The Legal Risks in Marketing Your Practice: Ask the Attorney September 28, 2010 W. Kenneth Davis, Jr. Partner Katten Muchin Rosenman LLP Disclosure: NONE 2 Today s Discussion The laws: Federal Anti-Kickback
More informationFraud and Abuse. Current Trends and Enforcement Activities
Fraud and Abuse Current Trends and Enforcement Activities Agenda Background Overview of Key Fraud and Abuse Laws Enforcement Recent Significant Cases and Trends Areas of Focus and Challenges for 2014 Identifying
More informationThe Financial Advisor s Guide to Social Media Regulations
The Financial Advisor s Guide to Social Media Regulations For US, UK and Canada With the right preparation and attention to detail, firms should feel confident about their ability to reach out to customers
More informationSocial Media. The Good, The Bad, The Really Ugly
Social Media The Good, The Bad, The Really Ugly Hospitals Using Social Media No longer a luxury it s a necessity Bottom Line It expands our reach to a broader audience Allows us to disseminate health information
More informationKeeping our Focus: Compliance Summary for Customers and Health Care Professionals. Understanding the Olympus Health Care Compliance Code of Conduct
Keeping our Focus: Compliance Summary for Customers and Health Care Professionals Understanding the Olympus Health Care Compliance Code of Conduct Introduction Olympus Corporation of the Americas ( Olympus
More informationCompliance in an Outsourced World
Compliance in an Outsourced World HCCA Compliance Institute April 26-29, 29, 2009 Karen D. Wilson Citadel Compliance Group, LLC Dallas, Texas www.citadelcompliance citadelcompliance.com information@citadelcompliance.com
More informationRegulation of Prescription Drug Promotion
Regulation of Prescription Drug Promotion Amy Toscano, Pharm.D., RAC, CPA Team Leader Office of Prescription Drug Promotion Food and Drug Administration June 2013 Overview Office of Prescription Drug Promotion
More informationFraud, Waste and Abuse Prevention Training
Fraud, Waste and Abuse Prevention Training The Centers for Medicare & Medicaid Services (CMS) requires annual fraud, waste and abuse training for organizations providing health services to MA or Medicare
More informationMedicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies
Medicare Compliance, Fraud, Waste and Abuse Training for Medicare Part D- Contracted Pharmacies 2008 Medco Health Solutions, Inc. All rights reserved. Training Introduction In this training, you ll learn
More informationWHISTLE BLOWING POLICY & PROCEDURES
Management Circular No: GCSL/01.2013 Revised: 01/2014 WHISTLE BLOWING POLICY & PROCEDURES All rights reserved. No part contained in this Policy may be reproduced or copied in any form without the written
More informationAHCA MEMBER GUIDANCE IMPLEMENTING THE FALSE CLAIMS ACT EDUCATIONAL PROVISIONS OF THE DEFICIT REDUCTION ACT
AHCA MEMBER GUIDANCE IMPLEMENTING THE FALSE CLAIMS ACT EDUCATIONAL PROVISIONS OF THE DEFICIT REDUCTION ACT THE TOPIC: Section 6033 of the Deficit Reduction Act of 2005 ( DRA ) requires entities that make
More informationRegulation of Lawyer Advertising Proposed Changes to the S.C. Rules of Professional Conduct
Regulation of Lawyer Advertising Proposed Changes to the S.C. Rules of Professional Conduct RULE 1.0 DEFINITIONS (additions) a) Advertise: To disseminate an advertisement or cause an advertisement to be
More informationCan You Get Insurance Coverage for False Claims Act and Similar Claims? Making Sure You ve Looked at All Possible Avenues of Recovery
Can You Get Insurance Coverage for False Claims Act and Similar Claims? Making Sure You ve Looked at All Possible Avenues of Recovery Presented by Brennan Torregrossa Asst. General Counsel Dispute Resolution
More informationArthur Rotatori, McGlinchey Stafford, PLLC Jason Romrell, LeadsMarket.com Dustin Alonzo, McGlinchey Stafford, PLLC. #LEND360 LEND360.
Arthur Rotatori, McGlinchey Stafford, PLLC Jason Romrell, LeadsMarket.com Dustin Alonzo, McGlinchey Stafford, PLLC #LEND360 LEND360.org Overview of Federal, State & Industry Regula9on Federal Trade Commission
More informationM INISTRY H EALTH CARE
M INISTRY H EALTH CARE CORPORATE POSITION STATEMENT TITLE: FRAUD AND ABUSE LAWS AND PROTECTIONS Origination Date: December, 2006 DRAFT/REV: December 7, 2007 Effective Date: January, 2007 Scope: Ministry
More informationReversing OutMigration Michelle Rathman Batschke Impact! Communications
Energy, Momentum, Motion Changing Community Perception Strategies for Reversing Outmigration Copyright 2012 by, Inc No part of this presentation can be reproduced or distributed without written consent.
More informationUniversity of Central Florida College of Medicine Industry Relations Policy and Guidelines. Table of Contents
University of Central Florida College of Medicine Industry Relations Policy and Guidelines 1. Introduction and Scope of Policy 2. Statement of Policy Table of Contents 3. Gifts and Individual Financial
More informationElectronic Security Association, Inc. Code of Ethics and Standards of Conduct Amended May 14, 2010 by Executive Committee
Electronic Security Association, Inc. Code of Ethics and Standards of Conduct Amended May 14, 2010 by Executive Committee Members of the Electronic Security Association ( ESA ), f/k/a National Burglar
More informationCode of Conduct and Business Ethics
Code of Conduct and Business Ethics Table of Contents Overview... 1 Compliance and Reporting Policy... 3 Non-Retaliation Policy... 4 Respect for All... 4 Equal Opportunity and Nondiscrimination... 4 Harassment...
More informationAddressing Government Investigations. Marcos Daniel Jimenez Partner
Addressing Government Investigations Marcos Daniel Jimenez Partner November 14, 2014 Agenda Statistics Key Players Fraud and Abuse Laws Potential Consequences Mitigation Strategies 2 Key Health Care Fraud
More informationbranding guide for tax pros
by Your Business Matters the branding guide for tax pros how to grow your tax business by building a powerful brand What s in this guide? What branding means Why branding matters in your tax practice How
More informationBLOGGING AND NEW MEDIA DISCLOSURE INFORMATION
BLOGGING AND NEW MEDIA DISCLOSURE INFORMATION Blogging and New Media Disclosures: What You Need to Know Where disclosure language should be placed in blog posts What types of compensation and relationships
More informationManaging Research Compliance Risks
Managing Research Compliance Risks James Moran, J.D., CPA Executive Director of Compliance, University of Pennsylvania School of Medicine Rick Rohrbach, MBA, CPA Senior Manager, Healthcare Consulting Practice
More informationA summary of administrative remedies found in the Program Fraud Civil Remedies Act
BLACK HILLS SPECIAL SERVICES COOPERATIVE'S POLICY TO PROVIDE EDUCATION CONCERNING FALSE CLAIMS LIABILITY, ANTI-RETALIATION PROTECTIONS FOR REPORTING WRONGDOING AND DETECTING AND PREVENTING FRAUD, WASTE
More informationWARNING LETTER DEPARTMENT OF HEALTH & HUMAN SERVICES TRANSMITTED BY FACSIMILE
DEPARTMENT OF HEALTH & HUMAN SERVICES Public Health Service Food and Drug Administration Rockville, MD 20857 TRANSMITTED BY FACSIMILE Peter A. Lankau President and CEO 100 Endo Boulevard Chadds Ford, PA
More informationMitigating Compliance
6 Baltzer Science Publishers Mitigating Compliance Risks Across The Sales Execution Cycle Wendy Heckelman* U.S. Government regulators are focusing on a wider range of sales practices in their investigations
More informationLIBRARY GUIDE: Pharmaceutical Sales & Marketing
LIBRARY GUIDE: Pharmaceutical Sales & Marketing Page 2 Pharmaceutical Sales and Marketing Course Library Table of Contents: Courses Listed by Functional Area... 4 Basics of the PhRMA Code (PHSM01)...5
More informationCode of Conduct. Compliance W.I.N.S Worldwide Integrity is Necessary for Success
Code of Conduct Compliance W.I.N.S Worldwide Integrity is Necessary for Success Effective February 2014 Disclaimer BEFORE YOU BEGIN You are being provided this certification to assist you in meeting your
More informationCongressman Harold Hal Rogers, 5th Congressional District, Kentucky. Orlando, FL April 2-4, 2013 N A T I O N A L RX DRUG ABUSE SUMMIT
We cannot afford to ignore the fast-growing drug problem in America. It impacts everything from medical expenses to workforce viability and it requires a multi-faceted approach with support, from not only
More informationAligning Compliance Program Priorities with Business Objectives
Aligning Compliance Program Priorities with Business Objectives By Jay G. Martin Vice President, Chief Compliance Officer and Senior Deputy General Counsel Baker Hughes Incorporated CAIL Institute for
More informationInformation for Law Firms On Public Relations
Information for Law Firms On Public Relations USING PUBLIC RELATIONS TO PROMOTE YOUR FIRM Public relations is an extremely broad heading and can be used to cover a wide range of activities undertaken by
More informationDealer Advertising: New Federal Compliance Mandates
Dealer Advertising: New Federal Compliance Mandates Randy Henrick Associate General Counsel Dealertrack, Inc. Lake Success, NY randy.henrick@dealertrack.com 516-734-3644 The views and opinions presented
More informationWhat is a Compliance Program?
Course Objectives Learn about the most important elements of the compliance program; Increase awareness and effectiveness of our compliance program; Learn about the important laws and what the government
More informationHealth Care Compliance Association 888-580-8373 www.hcca-info.org
Volume Thirteen Number Eleven Published Monthly Meet Dwight Claustre, Long-time HCCA Compliance Institute enthusiast page 15 Feature Focus: Civil and criminal liability for overpayments page 26 inside
More informationOFFICE OF INSPECTOR GENERAL
OFFICE OF INSPECTOR GENERAL SPECIAL ADVISORY BULLETIN Practices of Business Consultants June 2001 INTRODUCTION The Office of Inspector General (OIG) was established at the Department of Health and Human
More informationMISLEADING ADVERTISING GUIDE
MISLEADING ADVERTISING GUIDE Complying with The Competition Act CREA THE CANADIAN REAL ESTATE ASSOCIATION Table of Contents Introduction...............................................2 What is Misleading
More information1 st Tier & Downstream Training Focus
Colorado Access Advantage (HMO) Medicare Advantage Part D Fraud, Waste and Abuse Compliance Training 2010 Introduction 2 The Centers for Medicare & Medicaid Services (CMS) requires annual fraud, waste
More informationNewYork-Presbyterian Hospital Sites: All Centers Hospital Policy and Procedure Manual Number: D160 Page 1 of 9
Page 1 of 9 TITLE: FEDERAL DEFICIT REDUCTION ACT OF 2005 FRAUD AND ABUSE PROVISIONS POLICY: NewYork- Presbyterian Hospital (NYP or the Hospital) is committed to preventing and detecting any fraud, waste,
More informationCAN-SPAM Policy & Data Verification Guide
BIZ SERVICE PROVIDER CAN-SPAM Compliance & Data Verification Policy Document BSP CAN-SPAM Policy & Data Verification Guide BSP Page 1 of 5 Version 8.1 Effective Date; May 2015 BIZ SERVICE PROVIDER I. Summary
More informationMarketing, e-commerce and advertising in the pharmaceutical industry: France, the UK and the US
Life Sciences 2007/08 Marketing, e-commerce and advertising in the pharmaceutical industry: France, the UK and the US Alison Dennis, Paule Drouault-Gardrat and Areta Kupchyk, Reed Smith www.practicallaw.com/0-379-0848
More informationHealth Insurance Portability and Accountability Act (HIPAA)
Health Insurance Portability and Accountability Act (HIPAA) General Education Presented by: Bureau of Personnel Department of Health Department of Human Services Department of Social Services Bureau of
More informationRichard Nemeth, Esq. Nemeth & Associates, LLC 526 Superior Ave., East Suite 1120 Cleveland, OH 44114-1410 216/502-1300 rnemeth@ohbklaw.
Richard Nemeth, Esq. Nemeth & Associates, LLC 526 Superior Ave., East Suite 1120 Cleveland, OH 44114-1410 216/502-1300 rnemeth@ohbklaw.com To: Honorable Jim Hughes, Chairman Senate Financial Institutions
More informationA Roadmap for New Physicians. Avoiding Medicare and Medicaid Fraud and Abuse
A Roadmap for New Physicians Avoiding Medicare and Medicaid Fraud and Abuse Introduction This tutorial is intended to assist new physicians in understanding how to comply with Federal laws that combat
More informationGlobal Social Media Policy
Page 1 of 11 Global Social Media Policy Social Media describes the online tools that people use to share content, profiles, opinions, insights, experiences, perspectives and media itself, thus facilitating
More informationRisk Assessment and Management: A Regulatory Lawyer s Perspective
Risk Assessment and Management: A Regulatory Lawyer s Perspective Presented By: Alan G. Minsk Partner and Leader, Food and Drug Practice Team Arnall Golden Gregory LLP 171 17 th Street, NW, Suite 2100
More informationEleven Things to Know About the False Claims Act
Eleven Things to Know About the False Claims Act Scott Becker, Partner 312.750.6016 sbecker@mcguirewoods.com Julie Ann Sullivan, Associate 312.849.8116 jsullivan@mcguirewoods.com 77 West Wacker Drive,
More information